The effect of early, comprehensive genomic testing on clinical care in neonatal diabetes: An international cohort study

The Lancet

Volumn 386, Issue 9997, 2015, Pages 957-963

  De Franco, Elisa ^a   Flanagan, Sarah E ^a   Houghton, Jayne A L ^a   Allen, Hana Lango ^a   MacKay, Deborah J G ^b,c,d   Temple, I Karen ^b,c   Ellard, Sian ^a   Hattersley, Andrew T ^a  

^a UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

^b SALISBURY NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

POTASSIUM CHANNEL; SULFONYLUREA;

ARTICLE; CHROMOSOME 6Q; CLINICAL FEATURE; CONSANGUINITY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENE MUTATION; GENETIC SCREENING; HUMAN; MAJOR CLINICAL STUDY; MALE; METHYLATION; NEWBORN; NEWBORN DISEASE; NEXT GENERATION SEQUENCING; PHENOTYPE; PRIORITY JOURNAL; CLASSIFICATION; CLINICAL TRIAL; GENETICS; INFANT; MULTICENTER STUDY; MUTATION; PROCEDURES;

DIABETES MELLITUS; FEMALE; GENETIC TESTING; HUMANS; INFANT; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; MALE; MUTATION;

EID: 84941425331     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(15)60098-8     Document Type: Article

References (38)

1. D Iafusco, O Massa, B Pasquino the Early Diabetes Study Group of ISPED Minimal incidence of neonatal/infancy onset diabetes in Italy is 1:90,000 live births Acta Diabetol 49 2012 405 408
2. AS Slingerland, BM Shields, SE Flanagan et al. Referral rates for diagnostic testing support an incidence of permanent neonatal diabetes in three European countries of at least 1 in 260000 live births Diabetologia 52 2009 1683 1685
3. EL Edghill, RJ Dix, SE Flanagan et al. HLA genotyping supports a nonautoimmune etiology in patients diagnosed with diabetes under the age of 6 months Diabetes 55 2006 1895 1898
4. D Iafusco, MA Stazi, R Cotichini the Early Onset Diabetes Study Group of the Italian Society of Paediatric Endocrinology and Diabetology Permanent diabetes mellitus in the first year of life Diabetologia 45 2002 798 804
5. AL Gloyn, ER Pearson, JF Antcliff et al. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes N Engl J Med 350 2004 1838 1849
6. P Proks, AL Arnold, J Bruining et al. A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes Hum Mol Genet 15 2006 1793 1800
7. AP Babenko, M Polak, H Cavé et al. Activating mutations in the ABCC8 gene in neonatal diabetes mellitus N Engl J Med 355 2006 456 466
8. JV Sagen, H Raeder, E Hathout et al. Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy Diabetes 53 2004 2713 2718
9. ER Pearson, I Flechtner, PR Njolstad, et al, and the Neonatal Diabetes International Collaborative Group Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations N Engl J Med 355 2006 467 477
10. E Codner, S Flanagan, S Ellard, H García, AT Hattersley High-dose glibenclamide can replace insulin therapy despite transitory diarrhea in early-onset diabetes caused by a novel R201L Kir6.2 mutation Diabetes Care 28 2005 758 759
11. M Rafiq, SE Flanagan, AM Patch, BM Shields, S Ellard, AT Hattersley the Neonatal Diabetes International Collaborative Group Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations Diabetes Care 31 2008 204 209
12. A Hattersley, J Bruining, J Shield, P Njolstad, K Donaghue the International Society for Pediatric and Adolescent Diabetes ISPAD Clinical Practice Consensus Guidelines 2006-2007. The diagnosis and management of monogenic diabetes in children Pediatr Diabetes 7 2006 352 360
13. A Bonnefond, J Philippe, E Durand et al. Highly sensitive diagnosis of 43 monogenic forms of diabetes or obesity through one-step PCR-based enrichment in combination with next-generation sequencing Diabetes Care 37 2014 460 467
14. S Ellard, H Lango Allen, E De Franco et al. Improved genetic testing for monogenic diabetes using targeted next-generation sequencing Diabetologia 56 2013 1958 1963
15. R Gao, Y Liu, AP Gjesing et al. Evaluation of a target region capture sequencing platform using monogenic diabetes as a study-model BMC Genet 15 2014 13
16. AH Bittles A community genetics perspective on consanguineous marriage Community Genet 11 2008 324 330
17. ES Lander, D Botstein Homozygosity mapping: a way to map human recessive traits with the DNA of inbred children Science 236 1987 1567 1570
18. SE Flanagan, AM Patch, JM Locke et al. Genome-wide homozygosity analysis reveals HADH mutations as a common cause of diazoxide-responsive hyperinsulinemic-hypoglycemia in consanguineous pedigrees J Clin Endocrinol Metab 96 2011 E498 E502
19. O Rubio-Cabezas, SE Flanagan, A Damhuis, AT Hattersley, S Ellard KATP channel mutations in infants with permanent diabetes diagnosed after 6 months of life Pediatr Diabetes 13 2012 322 325
20. DJ Mackay, IK Temple, JP Shield, DO Robinson Bisulphite sequencing of the transient neonatal diabetes mellitus DMR facilitates a novel diagnostic test but reveals no methylation anomalies in patients of unknown aetiology Hum Genet 116 2005 255 261
21. M Delépine, M Nicolino, T Barrett, M Golamaully, GM Lathrop, C Julier EIF2AK3, encoding translation initiation factor 2-alpha kinase 3, is mutated in patients with Wolcott-Rallison syndrome Nat Genet 25 2000 406 409
22. J Stoy, EL Edghill, SE Flanagan the Neonatal Diabetes International Collaborative Group Insulin gene mutations as a cause of permanent neonatal diabetes Proc Natl Acad Sci USA 104 2007 15040 15044
23. I Garin, EL Edghill, I Akerman, et al, and the Neonatal Diabetes International Group Recessive mutations in the INS gene result in neonatal diabetes through reduced insulin biosynthesis Proc Natl Acad Sci USA 107 2010 3105 3110
24. AE Shearer, AP DeLuca, MS Hildebrand et al. Comprehensive genetic testing for hereditary hearing loss using massively parallel sequencing Proc Natl Acad Sci USA 107 2010 21104 21109
25. CA Valencia, A Ankala, D Rhodenizer et al. Comprehensive mutation analysis for congenital muscular dystrophy: a clinical PCR-based enrichment and next-generation sequencing panel PLoS One 8 2013 e53083
26. J O'Sullivan, BG Mullaney, SS Bhaskar et al. A paradigm shift in the delivery of services for diagnosis of inherited retinal disease J Med Genet 49 2012 322 326
27. RJ Gardner, DJ Mackay, AJ Mungall et al. An imprinted locus associated with transient neonatal diabetes mellitus Hum Mol Genet 9 2000 589 596
28. IK Temple, RJ Gardner, DO Robinson et al. Further evidence for an imprinted gene for neonatal diabetes localised to chromosome 6q22-q23 Hum Mol Genet 5 1996 1117 1121
29. IK Temple, JP Shield Transient neonatal diabetes, a disorder of imprinting J Med Genet 39 2002 872 875
30. SE Flanagan, AM Patch, DJ Mackay et al. Mutations in ATP-sensitive K+ channel genes cause transient neonatal diabetes and permanent diabetes in childhood or adulthood Diabetes 56 2007 1930 1937
31. AL Gloyn, F Reimann, C Girard et al. Relapsing diabetes can result from moderately activating mutations in KCNJ11 Hum Mol Genet 14 2005 925 934
32. K Busiah, S Drunat, L Vaivre-Douret et al. Neuropsychological dysfunction and developmental defects associated with genetic changes in infants with neonatal diabetes mellitus: a prospective cohort study Lancet Diabetes Endocrinol 1 2013 199 207
33. C Julier, M Nicolino Wolcott-Rallison syndrome Orphanet J Rare Dis 5 2010 29
34. P Proks, JF Antcliff, J Lippiat, AL Gloyn, AT Hattersley, FM Ashcroft Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features Proc Natl Acad Sci USA 101 2004 17539 17544
35. AS Slingerland, R Nuboer, M Hadders-Algra, AT Hattersley, GJ Bruining Improved motor development and good long-term glycaemic control with sulfonylurea treatment in a patient with the syndrome of intermediate developmental delay, early-onset generalised epilepsy and neonatal diabetes associated with the V59M mutation in the KCNJ11 gene Diabetologia 49 2006 2559 2563
36. K Shimomura, F Hörster, H de Wet et al. A novel mutation causing DEND syndrome: a treatable channelopathy of pancreas and brain Neurology 69 2007 1342 1349
37. TA Chatila, F Blaeser, N Ho et al. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome J Clin Invest 106 2000 R75 R81
38. F Barzaghi, L Passerini, R Bacchetta Immune dysregulation, polyendocrinopathy, enteropathy, x-linked syndrome: a paradigm of immunodeficiency with autoimmunity Front Immunol 3 2012 211